Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
AstraZeneca
Moodys
Johnson and Johnson
Colorcon

Last Updated: June 27, 2022

LUTRATE DEPOT KIT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Lutrate Depot Kit, and when can generic versions of Lutrate Depot Kit launch?

Lutrate Depot Kit is a drug marketed by Gp-pharm Sa and is included in one NDA.

The generic ingredient in LUTRATE DEPOT KIT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Lutrate Depot Kit

A generic version of LUTRATE DEPOT KIT was approved as leuprolide acetate by SANDOZ on August 4th, 1998.

  Try it Free

Summary for LUTRATE DEPOT KIT
Drug patent expirations by year for LUTRATE DEPOT KIT
Recent Clinical Trials for LUTRATE DEPOT KIT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
City of Hope Medical CenterPhase 2
National Cancer Institute (NCI)Phase 2
ECOG-ACRIN Cancer Research GroupPhase 3

See all LUTRATE DEPOT KIT clinical trials

US Patents and Regulatory Information for LUTRATE DEPOT KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gp-pharm Sa LUTRATE DEPOT KIT leuprolide acetate FOR SUSPENSION;INTRAMUSCULAR 205054-001 Aug 28, 2018 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for LUTRATE DEPOT KIT

See the table below for patents covering LUTRATE DEPOT KIT around the world.

Country Patent Number Title Estimated Expiration
Australia 2173501 See Plans and Pricing
Brazil PI0008197 microcápsulas para a liberação prolongada de fármacos See Plans and Pricing
Germany 60001717 See Plans and Pricing
European Patent Office 1151746 MICROCAPSULES POUR LA LIBERATION PROLONGEE DE MEDICAMENTS (MICROCAPSULES FOR SUSTAINED RELEASE OF DRUGS) See Plans and Pricing
Austria 234608 See Plans and Pricing
Brazil 0008197 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Moodys
Baxter
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.